Immunostimulation is a rational therapeutic strategy in sepsis

Novartis Foundation Symposium

Volumn 280, Issue , 2007, Pages 21-27

  Pugin, Jérôme ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; REVIEW; SEPSIS;

HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; SEPSIS;

EID: 34247177126     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (24)

1. Abraham E 1999 Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25:556-566
2. Cavaillon JM, Adrie C, Fitting C Adib-Conquy M 2005 Reprogramming of circulatory cells in sepsis and SIRS. J Endotox Res 11:311-320
3. Dinarello CA 1991 The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 163:1177-1184
4. Docke WD, Randow F, Syrbe U et al 1997 Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678-681
5. Dugernier TL, Laterre PF, Wittebole X et al 2003 Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 168:148-157
6. Fumeaux T, Pugin J 2002 Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166: 1475-1482
7. Fumeaux T, Dufour J, Stern S, Pugin J 2004 Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 30:2028-2037
8. Goldie AS, Fearon KC, Ross JA et al 1995 Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 274:172-177
9. Hotchkiss RS, Karl IE 2003 The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150
10. Hotchkiss RS, Swanson PE, Freeman BD et al 1999 Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230-1251
11. Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G 1998 High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 26:1076-1082
12. Lissner R, Struff WG, Autenrieth IB, Woodcock BG, Karch H 1999 Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg Suppl 17-25
13. Meakins JL 1975 Host defence mechanisms: evaluation and roles of acquired defects and immunotherapy. Can J Surg 18:259-268
14. Monneret G, Lepape A, Voirin N et al 2006 Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175-1183
15. Munford RS, Pugin J 2001a Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316-321
16. Munford RS, Pugin J 2001b The crucial role of systemic responses in the innate (non-adaptive) host defense. J Endotox Res 7:327-332
17. Nierhaus A, Montag B, Timmler N et al 2003 Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive care Med 29:646-651
18. Payen D, Faivre V, Lukaszewicz AC, Losser MR 2000 Assessment of immunological status in the critically ill. Minerva Anesthesiol 66:351-357
19. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR 1996 Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 153:1850-1856
20. Pugin J, Verghese G, Widmer MC, Matthay MA 1999 The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27:304-312
21. Rodriguez A, Rello J, Neira J et al 2005 Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock 23:298-304
22. Rosenbloom AJ, Linden PK, Dorrance A, Penkosky N, Cohen-Melamed MH, Pinsky MR 2005 Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest 127:2139-2150
23. Schultz MJ, van der Poll T 2002 Animal and human models for sepsis. Ann Med 34:573-581
24. Volk HD, Reinke P, Docke WD 2000 Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 74:162-177